Sven Koscielny

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

Hartmut P.H. Neumann, Zoran Erlic, Carsten C. Boedeker et al. · Cancer Research · 2009 · 194 citations · Full text

Neck Paraganglioma Patients, Genetic Testing, Genetics +20

A Technical Triade for Proteomic Identification and Characterization of Cancer Biomarkers

Christian Melle, Günther Ernst, Bettina Schimmel et al. · Cancer Research · 2004 · 100 citations

Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip® Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and Immunohistochemistry

Christian Melle, Günther Ernst, Bettina Schimmel et al. · Molecular & Cellular Proteomics · 2003 · 92 citations · Full text

Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods

Susanne Singer, Helge Danker, Andreas Dietz et al. · Psycho-Oncology · 2007 · 83 citations

Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer.

Ulrike Riese, Regine Dahse, Walter Fiedler et al. · International Journal of Molecular Medicine · 1999 · 56 citations

Neck Cancer, Pathology, P16 Methylation Inactivation +16